retatrutide health canada approval When Will Retatrutide Be Available in Canada? 2027 Timeline

ALERT: Health officials have warned "do not buy this product, do not use this product" after six Victorians developed liver damage from using an unapproved peptide, Retatrutide. The experimental peptide, which officials

What does the science say about the effectiveness of oral GLP-1 medications? A new clinical trial from Weill Cornell Medicine and @nyphospital included patients who had lost significant weight on an injectable

Maximizing GLP-1 Market Exclusivity: Leveraging Patent Term Extension (PTE) and NCE Exclusivity to Protect Blockbuster Status - DrugPatentWatch Transform Data into Market Domination

Reports claim that a single well-connected patient received early access to Eli Lilly's experimental weight-loss drug, Retatrutide, through the FDA's compassionate use program before approval. The patient was reportedly 79 years old,

Novo Nordisk Signs Deal with Hims & Hers | PharmExec

Warning dodgy fat jab is becoming the 'new steroids' as rogue gym dealers fuel dangerous black market boom